PRMT2 (122), PRMT9 (123) had previously been shown to accelerate the development, invasion and metastasis of hepatocellular carcinoma, however, PRMT5 was found to inhibit the growth of HCC (124). Here, PRMT9 is linked to hepatocellular carcinoma.